OverviewSuggest Edit

    PARI is a company that manufactures medical devices with a focus on nebulizer systems. It offers inhalation devices and solutions for diagnosis, monitoring, and treatment of pulmonary, bronchial, and nasopharyngeal diseases.

    HQStarnberg, DE
    Employee Ratings3.8

    Latest Updates

    Employees (est.) (Apr 2022)179(+10%)
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at PARI

    Johann Zimmermann

    Johann Zimmermann

    Jürgen Müller

    Jürgen Müller

    President PARI GmbH, PARItec and PARI Medical Holding
    Stefan Seemann

    Stefan Seemann

    President PARI Pharma
    Show more

    PARI Office Locations

    PARI has offices in Starnberg, Midlothian, Nanterre and Byfleet
    Starnberg, DE (HQ)
    Moosstraße 3
    Nanterre, FR
    11 Avenue de l'Île Saint-Martin
    Byfleet, GB
    Unit 8, Oyster Park, 109 Chertsey Rd
    Midlothian, VA, US
    2412 Pari Way
    Show all (4)

    PARI Financials and Metrics

    Summary Metrics

    Founding Date


    PARI Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    PARI Online and Social Media Presence

    Embed Graph

    PARI News and Updates

    Global Pulmonary Drug Delivery Systems Market Report 2022, Featuring Philips Respironics, GlaxoSmithKline, Boehringer Ingelheim, 3M Healthcare and PARI GmbH

    Dublin, Jan. 17, 2022 (GLOBE NEWSWIRE) -- The "Pulmonary Drug Delivery Systems Market Forecasts to 2026" report has been added to's offering. The pulmonary drug delivery systems market is projected to grow at a CAGR of 4.83% to reach US$56.942 billion by 2026, from US$40.929…

    Dell Could Reinvent The Webcam Experience With Concept Pari

    While all of the ideas were interesting, the most fascinating (and potentially disruptive) is a wireless, mobile webcam called “Concept Pari.”

    Pulmotect's Positive Topline Results for Inhaled PUL-042 against COVID-19 Delivered by PARI Nebulizer

    MIDLOTHIAN, Va., Sept. 29, 2021 /PRNewswire/ -- Pulmotect reported positive topline results from their randomized, placebo-controlled Phase-2 trial of PUL-042 against COVID-19. Patients treated with inhaled PUL-042 had a statistically significant reduction in the time to improvement of...

    PARI Frequently Asked Questions

    • When was PARI founded?

      PARI was founded in 1906.

    • Who are PARI key executives?

      PARI's key executives are Johann Zimmermann, Jürgen Müller and Stefan Seemann.

    • How many employees does PARI have?

      PARI has 179 employees.

    • Who are PARI competitors?

      Competitors of PARI include Dutch Ophthalmic Research Center (DORC), Inogen and AuST.

    • Where is PARI headquarters?

      PARI headquarters is located at Moosstraße 3, Starnberg.

    • Where are PARI offices?

      PARI has offices in Starnberg, Midlothian, Nanterre and Byfleet.

    • How many offices does PARI have?

      PARI has 4 offices.